Diagnostic Imaging Intelligence Report
March 2010
FDA Warns GE, Bracco Over Contrast Agent Claims
The Food and Drug Administration (FDA) has sent notices of violation to GE Healthcare and Bracco Diagnostics for marketing claims related to their Visipaque and Isovue X-ray contrast agents.
Login | Subscribe
March 2010 - Table of Contents
Diagnostic Imaging Intelligence Report is part of...
Focus Areas |
Product Group |
 G2 Reports Medical Lab Management |
Subscription Products |